Knocked down GPR37 gene can reduce the invasion, migration, and proliferation ability of NSCLC cells, induce apoptosis, and increase the sensitivity to chemotherapy drugs, which plays a potential therapeutic role and might be a novel target for NSCLC treatment. Here, GPR37 is linked to non-small cell lung carcinoma.